. Referanser

Abbasi, N. R., Shaw, H. M., Rigel, D. S., Friedman, R. J., McCarthy, W. H., Osman, I., . . . Polsky, D. (2004). Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA, 292(22), 2771-2776.

Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. (1990). Arch Ophthalmol, 108(9), 1268-1273.

Agarwala, S. S. (2009). Current systemic therapy for metastatic melanoma. Expert Rev Anticancer Ther, 9(5), 587-595.

Agnese, D. M., Abdessalam, S. F., Burak, W. E., Jr., Magro, C. M., Pozderac, R. V., & Walker, M. J. (2003). Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery, 134(4), 542-547.

AJCC cancer staging manual/American Joint Committee on Cancer. (2010). New York: Springer.

Alexander, H. R., Jr., Libutti, S. K., Pingpank, J. F., Steinberg, S. M., Bartlett, D. L., Helsabeck, C., & Beresneva, T. (2003). Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res, 9(17), 6343-6349.

Amersi, F., & Morton, D. L. (2007). The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg, 41, 241-256.

Amin, M. B., Edge, S., Greene, F. L., Byrd, D. R., Brookland, R. K., Washington, M. K., & Gershenwald, J. E. (red.). (2017). AJCC Cancer Staging Manual (8. utg.). New York: Springer-Verlag.

Andtbacka, R. H., & Gershenwald, J. E. (2009). Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Canc Netw, 7(3), 308-317.

Antoniuk, P. M., Tjandra, J. J., Webb, B. W., Petras, R. E., Milsom, J. W., & Fazio, V. W. (1993). Anorectal malignant melanoma has a poor prognosis. International journal of colorectal disease, 8(2), 81-86. https://doi.org/10.1007/bf00299333

Ascierto, P. A., McArthur, G. A., Dreno, B., Larkin, J., Liszkay, G., Maio, M., . . . Ribas, A. (2014). coBRIM: A phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF^V600 mutation-positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519). Journal of Translational Medicine, 13(Suppl 1), O4.

Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. (2001). Arch Ophthalmol, 119(5), 670-676.

The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. (2007). Int J Cancer, 120(5), 1116-1122.

Balch, C. M., Gershenwald, J. E., Soong, S. J., Thompson, J. F., Atkins, M. B., Byrd, D. R., . . . Sondak, V. K. (2009). Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol, 27(36), 6199-6206.

Balch, C. M., Houghton, A. N., & Milton, G. W. (red.). (1992). Cutaneous Melanoma (2 utg.). (s. 165-99.). Philadelphia: Lippincott.

Balch, C. M., & Ross, M. I. (1999). Melanoma patients with iliac nodal metastases can be cured. Ann Surg Oncol, 6(3), 230-231.

Balch, C. M., Soong, S. J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., . . . Thompson, J. F. (2004). An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin, 54(3), 131-149; quiz 182-134.

Balch, C. M., Soong, S. J., Smith, T., Ross, M. I., Urist, M. M., Karakousis, C. P., . . . Desmond, R. (2001). Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol, 8(2), 101-108.

Bastiaannet, E., Wobbes, T., Hoekstra, O. S., van der Jagt, E. J., Brouwers, A. H., Koelemij, R., . . . Hoekstra, H. J. (2009). Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol, 27(28), 4774-4780. https://doi.org/10.1200/JCO.2008.20.1822

Beasley, G. M., Petersen, R. P., Yoo, J., McMahon, N., Aloia, T., Petros, W., . . . Tyler, D. S. (2008). Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol, 15(8), 2195-2205.

Bello, D. M., Chou, J. F., Panageas, K. S., Brady, M. S., Coit, D. G., Carvajal, R. D., & Ariyan, C. E. (2013). Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol, 20(11), 3618-3625. https://doi.org/10.1245/s10434-013-3089-0

Benlyazid, A., Thariat, J., Temam, S., Malard, O., Florescu, C., Choussy, O., . . . Filleron, T. (2010). Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Archives of otolaryngology--head & neck surgery, 136(12), 1219-1225. https://doi.org/10.1001/archoto.2010.217

Bergman, L., Seregard, S., Nilsson, B., Ringborg, U., Lundell, G., & Ragnarsson-Olding, B. (2002). Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci, 43(8), 2579-2583.

Bishop, D. T., Demenais, F., Goldstein, A. M., Bergman, W., Bishop, J. N., Bressac-de, P. B., . . . Tucker, M. A. (2002). Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst, 94(12), 894-903.

Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., . . . Bishop, J. A. (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet, 41(8), 920-925.

Bishop, J. N., Bataille, V., Gavin, A., Lens, M., Marsden, J., Mathews, T., & Wheelhouse, C. (2007). The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Clin Med, 7(3), 283-290.

Bishop, J. N., Harland, M., Randerson-Moor, J., & Bishop, D. T. (2007). Management of familial melanoma. Lancet Oncol., 8(1), 46-54.

Bochev, P., Klisarova, A., Kaprelyan, A., Chaushev, B., & Dancheva, Z. (2012). Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors. Hell J Nucl Med, 15(2), 125-129. 

Boldt, H. C., Byrne, S. F., Gilson, M. M., Finger, P. T., Green, R. L., Straatsma, B. R., . . . Hawkins, B. S. (2008). Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29. Ophthalmology, 115(8), 1390-1397.

Bottomley, A., Coens, C., Suciu, S., Santinami, M., Kruit, W., Testori, A., . . . Eggermont, A. (2009). Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol, 27(18), 2916-2923.

Bradford, P. T., Goldstein, A. M., McMaster, M. L., & Tucker, M. A. (2009). Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Archives of dermatology, 145(4), 427-434. https://doi.org/10.1001/archdermatol.2008.609

Brennum, J., Kosteljanetz, M., & Roed, H. M. (2002). Hjernemetastaser. Ugeskr Læger, 164(27), 3522-3526.

Bullard, K. M., Tuttle, T. M., Rothenberger, D. A., Madoff, R. D., Baxter, N. N., Finne, C. O., & Spencer, M. P. (2003). Surgical therapy for anorectal melanoma. Journal of the American College of Surgeons, 196(2), 206-211. https://doi.org/10.1016/s1072-7515(02)01538-7

Burmeister, B. H., Henderson, M. A., Ainslie, J., Fisher, R., Di Iulio, J., Smithers, B. M., . . . Thompson, J. F. (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol, 13(6), 589-597. https://doi.org/10.1016/s1470-2045(12)70138-9

Butler, P., Char, D. H., Zarbin, M., & Kroll, S. (1994). Natural history of indeterminate pigmented choroidal tumors. Ophthalmology, 101(4), 710-716.

Cancer Practice Guidelines for the Management of Melanoma in Australia and New Zealand: Evidence-based Best Practice Guidelines. (2008). Wellington: Cancer Council Australia/Australian Cancer Network/Ministry of Health, New Zealand. Hentet fra http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/ClinicalPracticeGuidelines-ManagementofMelanoma.pdf

Caraco, C., Celentano, E., Lastoria, S., Botti, G., Ascierto, P. A., & Mozzillo, N. (2004). Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters. Ann Surg Oncol, 11(3 Suppl), 198S-202S.

Cascinelli, N. (1998). Margin of resection in the management of primary melanoma. Semin Surg Oncol, 14(4), 272-275.

Chai, C. Y., Zager, J. S., Szabunio, M. M., Marzban, S. S., Chau, A., Rossi, R. M., & Sondak, V. K. (2012). Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma. Ann Surg Oncol, 19(4), 1100-1106. https://doi.org/10.1245/s10434-011-2172-7

Chakera, A. H., Hesse, B., Burak, Z., Ballinger, J. R., Britten, A., Caraco, C., . . . Testori, A. (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging, 36(10), 1713-1742.

Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., . . . McArthur, G. A. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med, 364(26), 2507-2516.

Char, D. H., & Miller, T. (1995). Accuracy of presumed uveal melanoma diagnosis before alternative therapy. Br J Ophthalmol, 79(7), 692-696.

Chopra, A., Sharma, R., & Rao, U. N. M. (2020). Pathology of Melanoma. Surg Clin North Am, 100(1), 43-59. https://doi.org/10.1016/j.suc.2019.09.004

Clark, W. H., Jr., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., . . . Halpern, A. C. (1989). Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst, 81(24), 1893-1904.

Cohn-Cedermark, G., Rutqvist, L. E., Andersson, R., Breivald, M., Ingvar, C., Johansson, H., . . . Ringborg, U. (2000). Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer, 89(7), 1495-1501.

Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., . . . Engh, A. M. (2019). Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(4), 367-402. https://doi.org/10.6004/jnccn.2019.0018

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. (2006). Arch Ophthalmol, 124(12), 1684-1693.

Cook, M. G., Massi, D., Szumera-Ciećkiewicz, A., Van den Oord, J., Blokx, W., van Kempen, L. C., . . . van Akkooi, A. C. J. (2019). An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma. Eur J Cancer, 114, 1-7. https://doi.org/10.1016/j.ejca.2019.03.010

Cutaneous melanoma. (2009). (5 utg.). Philadelphia: Lippingcott.

Damato, E. M., Damato, B., Sibbring, J. S., & Coupland, S. E. (2008). Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligation-dependent probe amplification. Graefes Arch Clin Exp Ophthalmol, 246(11), 1637-1640.

Danmark: Modermærkekræft. (2008). København: Sundhedsstyrelsen.

Daud, A. (2015). Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001. J Clin Oncol, 33(Suppl), abstr 9005.

de, V. E., Bray, F. I., Coebergh, J. W., & Parkin, D. M. (2003). Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer, 107(1), 119-126.

de, V. E., & Coebergh, J. W. (2004). Cutaneous malignant melanoma in Europe. Eur J Cancer, 40(16), 2355-2366.

de Wilt, J. H., van Akkooi, A. C., Verhoef, C., & Eggermont, A. M. (2008). Detection of melanoma micrometastases in sentinel nodes - the cons. Surg Oncol, 17(3), 175-181.

DeMatos, P., Tyler, D., & Seigler, H. F. (1998). Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery, 124(1), 38-48.

Desjardins, L., Lumbroso-Le, R. L., Levy-Gabriel, C., Dendale, R., Delacroix, S., Nauraye, C., . . . Asselain, B. (2006). Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res., 38(5), 255-260.

Dessinioti, C., Dimou, N., Geller, A. C., Stergiopoulou, A., Lo, S., Keim, U., . . . Stratigos, A. J. (2019). Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers. J Natl Cancer Inst, 111(12), 1314-1322. https://doi.org/10.1093/jnci/djz034

Dhar, K. K., Das, N., Brinkman, D. A., Beynon, J. L., & Woolas, R. P. (2007). Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 17(3), 720-723. 

Diener-West, M., Earle, J. D., Fine, S. L., Hawkins, B. S., Moy, C. S., Reynolds, S. M., . . . Straatsma, B. R. (2001). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol, 119(7), 969-982.

DMG Guidelines 2013. (2013). Herlev: Dansk Melanom Gruppe. Hentet fra http://www.melanoma.dk/

Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., . . . Flaherty, K. T. (2018). Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol, 19(10), 1315-1327. https://doi.org/10.1016/s1470-2045(18)30497-2

Dummer, R., Guggenheim, M., Arnold, A. W., Braun, R., & von Moos, R. (2011). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss medical weekly, 141, w13320. https://doi.org/10.4414/smw.2011.13320

Dummer, R., Schadendorf, D., Hauschild, A., Santinami, M., Atkinson, V. G., Mandala, M., . . . Long, G. V. (2018). 1250PEstimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial. Ann Oncol, 29(suppl_8), mdy289.006. https://doi.org/10.1093/annonc/mdy289.006

Egger, M. E., Stevenson, M., Bhutiani, N., Jordan, A. C., Scoggins, C. R., Philips, P., . . . McMasters, K. M. (2019). Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8(th) Edition American Joint Committee on Cancer Staging System? Journal of the American College of Surgeons, 228(4), 466-472. https://doi.org/10.1016/j.jamcollsurg.2018.12.030

Eggermont, A. M., Chiarion-Sileni, V., Grob, J. J., Dummer, R., Wolchok, J. D., Schmidt, H., . . . Testori, A. (2016). Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy. N Engl J Med, 375(19), 1845-1855. https://doi.org/10.1056/NEJMoa1611299

Eggermont, A. M., & Kirkwood, J. M. (2004). Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? Eur J Cancer, 40(12), 1825-1836.

Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., . . . Robert, C. (2018). Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. N Engl J Med, 378(19), 1789-1801. https://doi.org/10.1056/NEJMoa1802357

Eide, N., & Walaas, L. (2009). Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol, 87(6), 588-601.

Elwood, J. M., & Jopson, J. (1997). Melanoma and sun exposure: an overview of published studies. Int J Cancer, 73(2), 198-203.

Eskelin, S., & Kivela, T. (2002). Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol, 86(3), 333-338.

Eskelin, S., Pyrhonen, S., Hahka-Kemppinen, M., Tuomaala, S., & Kivela, T. (2003). A prognostic model and staging for metastatic uveal melanoma. Cancer, 97(2), 465-475.

Eskelin, S., Pyrhonen, S., Summanen, P., Prause, J. U., & Kivela, T. (1999). Screening for metastatic malignant melanoma of the uvea revisited. Cancer, 85(5), 1151-1159.

Faries, M. B., Thompson, J. F., Cochran, A., Elashoff, R., Glass, E. C., Mozzillo, N., . . . Morton, D. L. (2010). The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol, 17(12), 3324-3329.

Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., . . . Elashoff, R. M. (2017). Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med, 376(23), 2211-2222. https://doi.org/10.1056/NEJMoa1613210

Fenig, E., Eidelevich, E., Njuguna, E., Katz, A., Gutman, H., Sulkes, A., & Schechter, J. (1999). Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol, 22(2), 184-186.

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., . . . Bray, F. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49(6), 1374-1403.

Finger, P. T., Kurli, M., Reddy, S., Tena, L. B., & Pavlick, A. C. (2005). Whole body PET/CT for initial staging of choroidal melanoma. Br J Ophthalmol, 89(10), 1270-1274.

Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., . . . Chapman, P. B. (2010). Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med, 363(9), 809-819.

Folberg, R., Rummelt, V., Parys-Van, G. R., Hwang, T., Woolson, R. F., Pe'er, J., & Gruman, L. M. (1993). The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology, 100(9), 1389-1398.

Foster, R. D., Williams, M. L., Barkovich, A. J., Hoffman, W. Y., Mathes, S. J., & Frieden, I. J. (2001). Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg, 107(4), 933-941.

Francken, A. B., Shaw, H. M., Accortt, N. A., Soong, S. J., Hoekstra, H. J., & Thompson, J. F. (2007). Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol, 14(6), 1924-1933. https://doi.org/10.1245/s10434-007-9347-2

Frenkel, S., Nir, I., Hendler, K., Lotem, M., Eid, A., Jurim, O., & Pe'er, J. (2009). Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol, 93(8), 1042-1046.

Friedman, R. J., Rigel, D. S., & Kopf, A. W. (1985). Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin, 35(3), 130-151. https://doi.org/10.3322/canjclin.35.3.130

Frumovitz, M., Etchepareborda, M., Sun, C. C., Soliman, P. T., Eifel, P. J., Levenback, C. F., & Ramirez, P. T. (2010). Primary malignant melanoma of the vagina. Obstetrics and gynecology, 116(6), 1358-1365. https://doi.org/10.1097/AOG.0b013e3181fb8045

Gallagher, R. P., Spinelli, J. J., & Lee, T. K. (2005). Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev, 14(3), 562-566.

Gandini, S., Raimondi, S., Gnagnarella, P., Dore, J. F., Maisonneuve, P., & Testori, A. (2009). Vitamin D and skin cancer: a meta-analysis. Eur J Cancer, 45(4), 634-641.

Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Abeni, D., Boyle, P., & Melchi, C. F. (2005). Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer, 41(1), 28-44.

Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer, 41(1), 45-60.

Ganley, J. P., & Comstock, G. W. (1973). Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol., 76(1), 19-25.

Garbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Reinhold, U., . . . Kaufmann, R. (2007). Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma research, 17(6), 393-399. https://doi.org/10.1097/CMR.0b013e3282f05039

Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Spatz, A., . . . Eggermont, A. M. (2012). Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012. Eur J Cancer, 48(15), 2375-2390. https://doi.org/10.1016/j.ejca.2012.06.013

Gershenwald, J. E., & Scolyer, R. A. (2018). Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol, 25(8), 2105-2110. https://doi.org/10.1245/s10434-018-6513-7

Ghiasvand, R., Rueegg, C. S., Weiderpass, E., Green, A. C., Lund, E., & Veierod, M. B. (2017). Indoor Tanning and Melanoma Risk: Long-Term Evidence From a Prospective Population-Based Cohort Study. American journal of epidemiology, 185(3), 147-156. https://doi.org/10.1093/aje/kww148

Ghiasvand, R., Weiderpass, E., Green, A. C., Lund, E., & Veierod, M. B. (2016). Sunscreen Use and Subsequent Melanoma Risk: A Population-Based Cohort Study. J Clin Oncol, 34(33), 3976-3983. https://doi.org/10.1200/jco.2016.67.5934

Gillgren, P., Drzewiecki, K. T., Niin, M., Gullestad, H. P., Hellborg, H., Månsson-Brahme, E., . . . Ringborg, U. (2011). 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet, 378(9803), 1635-1642.

Globocan 2008: estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. (2010). [nettside]. Lyon: IARC. Hentet 1 nov. 2013, fra http://globocan.iarc.fr/

Gold, J. S., Jaques, D. P., Busam, K. J., Brady, M. S., & Coit, D. G. (2007). Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy. Ann Surg Oncol, 14(7), 2133-2140. https://doi.org/10.1245/s10434-007-9399-3

Goldman, S., Glimelius, B., & Påhlman, L. (1990). Anorectal malignant melanoma in Sweden. Report of 49 patients. Diseases of the colon and rectum, 33(10), 874-877. https://doi.org/10.1007/bf02051925

Goldstein, A. M., Struewing, J. P., Chidambaram, A., Fraser, M. C., & Tucker, M. A. (2000). Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst, 92(12), 1006-1010.

Goodson, A. G., & Grossman, D. (2009). Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol, 60(5), 719-735.

Goyal, S., Silk, A. W., Tian, S., Mehnert, J., Danish, S., Ranjan, S., & Kaufman, H. L. (2015). Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review. JAMA Oncol, 1(5), 668-676. https://doi.org/10.1001/jamaoncol.2015.1206

Gragoudas, E., Li, W., Goitein, M., Lane, A. M., Munzenrider, J. E., & Egan, K. M. (2002). Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol, 120(12), 1665-1671.

Gragoudas, E. S., Li, W., Lane, A. M., Munzenrider, J., & Egan, K. M. (1999). Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology, 106(8), 1571-1577.

Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011). Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol, 29(3), 257-263.

Grunhagen, D. J., van, E. B., Brunstein, F., Graveland, W. J., van Geel, A. N., de Wilt, J. H., & Eggermont, A. M. (2005). Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol, 12(8), 609-615.

Guenel, P., Laforest, L., Cyr, D., Fevotte, J., Sabroe, S., Dufour, C., . . . Lynge, E. (2001). Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control, 12(5), 451-459.

Guggenheim, M. M., Hug, U., Jung, F. J., Rousson, V., Aust, M. C., Calcagni, M., . . . Giovanoli, P. (2008). Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg, 247(4), 687-693.

Gupta, S., Bedikian, A. Y., Ahrar, J., Ensor, J., Ahrar, K., Madoff, D. C., . . . Hwu, P. (2010). Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol., 33(5), 474-480.

Gyorki, D. E., Sanelli, A., Herschtal, A., Lazarakis, S., McArthur, G. A., Speakman, D., . . . Henderson, M. A. (2016). Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool. Ann Surg Oncol, 23(2), 579-584. https://doi.org/10.1245/s10434-015-4894-4

Haigh, P. I., DiFronzo, L. A., & McCready, D. R. (2003). Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Canadian journal of surgery. Journal canadien de chirurgie, 46(6), 419-426.

Hansson, J., Bergenmar, M., Hofer, P. A., Lundell, G., Mansson-Brahme, E., Ringborg, U., . . . Rosdahl, I. (2007). Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol, 25(19), 2819-2824.

Hansson, J., Aamdal, S., Brandberg, Y., Bastholt, L., Hernberg, M., Nilsson, B., . . . Group, N. M. C. (2011). Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma [2011 Asco Annual Meeting]. J Clin Oncol, 29(suppl), abstr. 8547.

Hauschild, A., Dummer, R., Schadendorf, D., Santinami, M., Atkinson, V., Mandala, M., . . . Long, G. V. (2018). Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma. J Clin Oncol, JCO1801219 [Epub ahead of print]. https://doi.org/10.1200/jco.18.01219

Hauschild, A., Grob, J. J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., . . . Chapman, P. B. (2012). Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet, 380(9839), 358-365. https://doi.org/10.1016/s0140-6736(12)60868-x

Haydu, L. E., Stollman, J. T., Scolyer, R. A., Spillane, A. J., Quinn, M. J., Saw, R. P., . . . Thompson, J. F. (2016). Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center. Ann Surg Oncol, 23(4), 1071-1081. https://doi.org/10.1245/s10434-015-4575-3

Hayes, A. J., Maynard, L., Coombes, G., Newton-Bishop, J., Timmons, M., Cook, M., . . . Thomas, J. M. (2016). Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. Lancet Oncol, 17(2), 184-192. https://doi.org/10.1016/s1470-2045(15)00482-9

Helsing, P., Nymoen, D. A., Ariansen, S., Steine, S. J., Maehle, L., Aamdal, S., . . . Andresen, P. A. (2008). Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes Chromosomes Cancer, 47(2), 175-184.

Hill, S., & Thomas, J. M. (1996). Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br J Surg, 83(4), 509-512.

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., . . . Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med, 363(8), 711-723.

Holly, E. A., Cress, R. D., & Ahn, D. K. (1995). Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol., 141(10), 943-950.

Holtkamp, L. H. J., Read, R. L., Emmett, L., Thompson, J. F., & Nieweg, O. E. (2017). Futility of imaging to stage melanoma patients with a positive sentinel lymph node. Melanoma research, 27(5), 457-462. https://doi.org/10.1097/CMR.0000000000000362

Hong, A. M., Fogarty, G. B., Dolven-Jacobsen, K., Burmeister, B. H., Lo, S. N., Haydu, L. E., . . . Thompson, J. F. (2019). Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial. J Clin Oncol, 37(33), 3132-3141. https://doi.org/10.1200/jco.19.01414

Hong, A. M., Suo, C., Valenzuela, M., Haydu, L. E., Jacobsen, K. D., Reisse, C. H., & Fogarty, G. (2014). Low incidence of melanoma brain metastasis in the hippocampus. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 111(1), 59-62. https://doi.org/10.1016/j.radonc.2014.01.012

Hudson, L. E., Maithel, S. K., Carlson, G. W., Rizzo, M., Murray, D. R., Hestley, A. C., & Delman, K. A. (2013). 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol, 20(1), 346-351. https://doi.org/10.1245/s10434-012-2543-8

Hughes, T. M., A'Hern, R. P., & Thomas, J. M. (2000). Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg, 87(7), 892-901.

Hunger, R. E., Seyed Jafari, S. M., Angermeier, S., & Shafighi, M. (2014). Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome. Br J Dermatol, 171(6), 1391-1396. https://doi.org/10.1111/bjd.13478

Haagensen, C. D. (1971). Diseases of the breast. Philadelphia: Saunders.

Irvin, W. P., Jr., Legallo, R. L., Stoler, M. H., Rice, L. W., Taylor, P. T., Jr., & Andersen, W. A. (2001). Vulvar melanoma: a retrospective analysis and literature review. Gynecologic oncology, 83(3), 457-465. https://doi.org/10.1006/gyno.2001.6337

Isager, P., Osterlind, A., Engholm, G., Heegaard, S., Lindegaard, J., Overgaard, J., & Storm, H. H. (2005). Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study. Ophthalmic Epidemiol., 12(4), 223-232.

Jampol, L. M., Moy, C. S., Murray, T. G., Reynolds, S. M., Albert, D. M., Schachat, A. P., . . . Wells, C. G. (2002). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology, 109(12), 2197-2206.

Jaramillo, B. A., Ganjei, P., Averette, H. E., Sevin, B. U., & Lovecchio, J. L. (1985). Malignant melanoma of the vulva. Obstetrics and gynecology, 66(3), 398-401.

Jensen, O. A. (1963). Malignant melanomas of the uvea in Denmark 1943-1952: a clinical, histopathological, and prognostic study. Acta Ophthalmol, 43(Suppl 75), 1-220.

Jimenez-Requena, F., Delgado-Bolton, R. C., Fernandez-Perez, C., Gambhir, S. S., Schwimmer, J., Perez-Vazquez, J. M., & Carreras-Delgado, J. L. (2010). Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma. Eur J Nucl Med Mol Imaging, 37(2), 284-300.

Johansen, C., Boice, J. D., Jr., McLaughlin, J. K., Christensen, H. C., & Olsen, J. H. (2002). Mobile phones and malignant melanoma of the eye. Br J Cancer, 86(3), 348-349.

Karagas, M. R., Stukel, T. A., Dykes, J., Miglionico, J., Greene, M. A., Carey, M., . . . Swerdlow, A. J. (2002). A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer, 86(7), 1085-1092.

Karakousis, C. P., Emrich, L. J., & Rao, U. (1986). Groin dissection in malignant melanoma. Am J Surg., 152(5), 491-495.

Karakousis, G. C., Pandit-Taskar, N., Hsu, M., Panageas, K., Atherton, S., Ariyan, C., & Brady, M. S. (2013). Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Res., 23(1), 40-46.

Katalinic, A., Waldmann, A., Weinstock, M. A., Geller, A. C., Eisemann, N., Greinert, R., . . . Breitbart, E. (2012). Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer, 118(21), 5395-5402. https://doi.org/10.1002/cncr.27566

Kelly, J. W., Chamberlain, A. J., Staples, M. P., & McAvoy, B. (2003). Nodular melanoma. No longer as simple as ABC. Australian family physician, 32(9), 706-709.

Kennedy, A. S., Nutting, C., Jakobs, T., Cianni, R., Notarianni, E., Ofer, A., . . . Dezarn, W. A. (2009). A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest, 27(6), 682-690.

Kesson, E. M., Allardice, G. M., George, W. D., Burns, H. J., & Morrison, D. S. (2012). Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (Clinical research ed.), 344, e2718. https://doi.org/10.1136/bmj.e2718

Keung, E. Z., & Gershenwald, J. E. (2018). The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther, 18(8), 775-784. https://doi.org/10.1080/14737140.2018.1489246

Kinsler, V. A., Birley, J., & Atherton, D. J. (2009). Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes. Br J Dermatol, 160(1), 143-150.

Kinsler, V. A., Chong, W. K., Aylett, S. E., & Atherton, D. J. (2008). Complications of congenital melanocytic naevi in children: analysis of 16 years' experience and clinical practice. Br J Dermatol, 159(4), 907-914.

Kirkwood, J. M., Manola, J., Ibrahim, J., Sondak, V., Ernstoff, M. S., & Rao, U. (2004). A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res, 10(5), 1670-1677.

Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002). Diagnostic accuracy of dermoscopy. Lancet Oncol., 3(3), 159-165.

Kivela, T., Eskelin, S., & Kujala, E. (2006). Metastatic uveal melanoma. Int Ophthalmol Clin, 46(1), 133-149.

Kodjikian, L., Grange, J. D., & Rivoire, M. (2005). Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy. Graefes Arch Clin Exp Ophthalmol, 243(6), 622-624.

Konstadoulakis, M. M., Ricaniadis, N., Walsh, D., & Karakousis, C. P. (1995). Malignant melanoma of the anorectal region. J Surg Oncol, 58(2), 118-120. https://doi.org/10.1002/jso.2930580209

Koskivuo, I., Kemppainen, J., Giordano, S., Seppänen, M., Veräjänkorva, E., Vihinen, P., & Minn, H. (2016). Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma(). Acta Oncol, 55(11), 1355-1359. https://doi.org/10.1080/0284186x.2016.1213879

Kreftregisteret. ( 2008). Personlig meddelelse

Kretschmer, L., Thoms, K. M., Peeters, S., Haenssle, H., Bertsch, H. P., & Emmert, S. (2008). Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res., 18(1), 16-21.

Kroon, H. M., & Thompson, J. F. (2009). Isolated limb infusion: a review. J Surg Oncol, 100(2), 169-177.

Kujala, E., Makitie, T., & Kivela, T. (2003). Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci, 44(11), 4651-4659.

Kullavanijaya, P., & Lim, H. W. (2005). Photoprotection. J Am Acad Dermatol, 52(6), 937-958.

Kyrgidis, A., Tzellos, T., Mocellin, S., Apalla, Z., Lallas, A., Pilati, P., & Stratigos, A. (2015). Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma. Cochrane Database Syst Rev, (5), CD010307. https://doi.org/10.1002/14651858.CD010307.pub2

Landi, S. (2009). Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature. Mutat Res, 681(2-3), 299-307.

Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Lao, C. D., . . . Wolchok, J. D. (2019). Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. The New England journal of medicine, 381(16), 1535-1546. https://doi.org/10.1056/NEJMoa1910836

Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., . . . Wolchok, J. D. (2015). Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med, 373(1), 23-34. https://doi.org/10.1056/NEJMoa1504030

Larsen, I. K. (red.). (2015). Cancer in Norway 2013: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2013/cin_2013.pdf

Larsen, I. K. (red.). (2019). Cancer in Norway 2018: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2018/cin2018.pdf

Lattanzi, M., Lee, Y., Simpson, D., Moran, U., Darvishian, F., Kim, R. H., . . . Osman, I. (2019). Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy. J Natl Cancer Inst, 111(2), 180-188. https://doi.org/10.1093/jnci/djy086

Leiter, U., Stadler, R., Mauch, C., Hohenberger, W., Brockmeyer, N., Berking, C., . . . Garbe, C. (2016). Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol, 17(6), 757-767. https://doi.org/10.1016/s1470-2045(16)00141-8

Lens, M. B., Dawes, M., Goodacre, T., & Bishop, J. A. (2002). Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg, 137(10), 1101-1105.

Lens, M. B., Nathan, P., & Bataille, V. (2007). Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg, 142(9), 885-891.

Leve med kreft: Nasjonal kreftstrategi (2018–2022). (2018). Oslo: Helse- og omsrogsdepartementet. Hentet fra https://www.regjeringen.no/contentassets/266bf1eec38940888a589ec86d79da20/regjeringens_kreftstrategi_180418.pdf

Liu, L. C., Parrett, B. M., Jenkins, T., Lee, W., Morita, E., Treseler, P., . . . Leong, S. P. (2011). Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye. Ann Surg Oncol, 18(10), 2919-2924.

Livingstone, E., Krajewski, C., Eigentler, T. K., Windemuth-Kieselbach, C., Benson, S., Elsenbruch, S., . . . Schadendorf, D. (2015). Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study. Eur J Cancer, 51(5), 653-667. https://doi.org/10.1016/j.ejca.2015.01.007

Long, G. V., Atkinson, V., Lo, S., Sandhu, S., Guminski, A. D., Brown, M. P., . . . McArthur, G. A. (2018). Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol, 19(5), 672-681. https://doi.org/10.1016/s1470-2045(18)30139-6

Long, G. V., Hauschild, A., Santinami, M., Atkinson, V., Mandala, M., Chiarion-Sileni, V., . . . Kirkwood, J. M. (2017). Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. N Engl J Med, 377(19), 1813-1823. https://doi.org/10.1056/NEJMoa1708539

Long, G. V., Trefzer, U., Davies, M. A., Kefford, R. F., Ascierto, P. A., Chapman, P. B., . . . Schadendorf, D. (2012). Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. Lancet Oncol, 13(11), 1087-1095. https://doi.org/10.1016/s1470-2045(12)70431-x

Lotem, M., Anteby, S., Peretz, T., Ingber, A., Avinoach, I., & Prus, D. (2003). Mucosal melanoma of the female genital tract is a multifocal disorder. Gynecologic oncology, 88(1), 45-50. https://doi.org/10.1006/gyno.2002.6848

Lucke, A. (1869). Die Lehre von den Geschwulsten in anatomishcer und klinischer Beziehung. I: Handbuch der allgemeinen und speciellen Chirurgie (s. 244). Enke: Erlangen.

Lynch, H. T., Fusaro, R. M., Lynch, J. F., & Brand, R. (2008). Pancreatic cancer and the FAMMM syndrome. Fam Cancer, 7(1), 103-112.

MacKie, R. M., Bray, C. A., Hole, D. J., Morris, A., Nicolson, M., Evans, A., . . . Vestey, J. (2002). Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet, 360(9333), 587-591.

Malignant melanoma of the uvea (B). I. (2009). S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, & A. Trotti (red.), AJCC cancer staging manual (s. 547-560). New York: Springer.

Malik, A., Hull, T. L., & Floruta, C. (2004). What is the best surgical treatment for anorectal melanoma? International journal of colorectal disease, 19(2), 121-123. https://doi.org/10.1007/s00384-003-0526-8

Mariani, P., Piperno-Neumann, S., Servois, V., Berry, M. G., Dorval, T., Plancher, C., . . . Salmon, R. J. (2009). Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol, 35(11), 1192-1197.

Marty, M., Sersa, G., Garbay, J. R., Gehl, J., Collins, C. G., Snoj, M., . . . Mir, L. M. (2006). Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl., 4(11), 3-13. 
https://doi.org/10.1016/j.ejcsup.2006.08.002

Maurichi, A., Miceli, R., Eriksson, H., Newton-Bishop, J., Nsengimana, J., Chan, M., . . . Santinami, M. (2020). Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram. J Clin Oncol, 38(14), 1591-1601. https://doi.org/10.1200/jco.19.01902

McLean, I. W., Ainbinder, D. J., Gamel, J. W., & McCurdy, J. B. (1995). Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location. Ophthalmology, 102(7), 1060-1064.

McMasters, K. M., Reintgen, D. S., Ross, M. I., Wong, S. L., Gershenwald, J. E., Krag, D. N., . . . Edwards, M. J. (2001). Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol, 8(3), 192-197.

Melanoma: assessment and management. (2015). (NICE guideline NG14). Cardiff: National Collaborating Centre for Cancer. Hentet fra http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0079031/pdf/PubMedHealth_PMH0079031.pdf

Melia, B. M., Abramson, D. H., Albert, D. M., Boldt, H. C., Earle, J. D., Hanson, W. F., . . . Weingeist, T. A. (2001). Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology, 108(2), 348-366.

MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelmarT) [pågående studie]. (2015-2026). (NCT02385214). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02385214

Mendenhall, W. M., Amdur, R. J., Grobmyer, S. R., George, T. J., Jr., Werning, J. W., Hochwald, S. N., & Mendenhall, N. P. (2008). Adjuvant radiotherapy for cutaneous melanoma. Cancer, 112(6), 1189-1196.

Menzies, A. M., Haydu, L. E., Visintin, L., Carlino, M. S., Howle, J. R., Thompson, J. F., . . . Long, G. V. (2012). Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res, 18(12), 3242-3249. https://doi.org/10.1158/1078-0432.ccr-12-0052

Menzies, A. M., Long, G. V., & Murali, R. (2012). Dabrafenib and its potential for the treatment of metastatic melanoma. Drug design, development and therapy, 6, 391-405. https://doi.org/10.2147/dddt.s38998

Meyer, T., Merkel, S., Goehl, J., & Hohenberger, W. (2000). Surgical therapy for distant metastases of malignant melanoma. Cancer, 89(9), 1983-1991.

Meyle, K. D., & Guldberg, P. (2009). Genetic risk factors for melanoma. Hum Genet, 126(4), 499-510.

Mihm, M. C., Jr., & Mule, J. J. (2015). Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response. Cancer immunology research, 3(8), 827-835. https://doi.org/10.1158/2326-6066.cir-15-0143

Miller, J. D. (1993). Surgical excision for single cerebral metastasis? Lancet, 341(8860), 1566.

Millward, M., Menzies, A., Atkinson, V., Brown, M., Haydon, A., & Cancer Council Australia Melanoma Guidelines Working Party. (25. mai 2018). What investigations should be performed when Stage IV melanoma is diagnosed? I: Clinical practice guidelines for the diagnosis and management of melanoma. [nettdokument]. Sydney: Cancer Council Australia. Hentet 17. mars 2020, fra https://wiki.cancer.org.au/australiawiki/index.php?oldid=186478

Mir, L. M., Gehl, J., Sersa, G., Collins, C. G., Garbay, J. R., Billard, V., . . . Marty, M. (2006). Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl., 4(11), 14-25.https://doi.org/10.1016/j.ejcsup.2006.08.003

Mocellin, S., Pasquali, S., & Nitti, D. (2011). The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg, 253(2), 238-243. https://doi.org/10.1097/SLA.0b013e318207a331

Mocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010). Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst, 102(7), 493-501.

Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M. F., Hayward, N. K., & Akslen, L. A. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer, 44(1), 10-18.

Moozar, K. L., Wong, C. S., & Couture, J. (2003). Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Canadian journal of surgery. Journal canadien de chirurgie, 46(5), 345-349.

Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. (1997). Arch Ophthalmol, 115(7), 886-893.

Morton, D. L. (2012). Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis, 29(7), 699-706.

Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., . . . Wang, H. J. (2006). Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med, 355(13), 1307-1317.

Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Nieweg, O. E., Roses, D. F., . . . Faries, M. B. (2014). Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med, 370(7), 599-609. https://doi.org/10.1056/NEJMoa1310460

Morton, D. L., Wen, D. R., Wong, J. H., Economou, J. S., Cagle, L. A., Storm, F. K., . . . Cochran, A. J. (1992). Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg, 127(4), 392-399.

Morton, R., Barbour, A., Bell, C., Mar, V., Smithers, M., & Cancer Council Australia Melanoma Guidelines Working Party. (25. mai 2018). What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients? I: Clinical practice guidelines for the diagnosis and management of melanoma. [nettdokument]. Sydney: Cancer Council Australia. Hentet 17. mars 2020, fra https://wiki.cancer.org.au/australiawiki/index.php?oldid=186474

Mudhar, H. S., Parsons, M. A., Sisley, K., Rundle, P., Singh, A., & Rennie, I. G. (2004). A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology, 45(1), 1-12.

Nasjonal strategi for kreftområdet 2006-2009. (2006). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/hod/sykehus/kreftstrategi-2006-2009.pdf

Nasjonalt handlingsprogram med retningslinjer for palliasjon i kreftomsorgen. (2019). (rev. utg.). (IS-2800). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-i-kreftomsorgen-handlingsprogram

Nasjonalt kvalitetsregister for melanom. (2019a). Figur 3.24 og 3.25. I: Årsrapport 2018 med resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for melanom. Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2019/arsrapport-2018-melanom.pdf

Nasjonalt kvalitetsregister for melanom. (2019b). Årsrapport 2018: resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for melanom. Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2019/arsrapport-2018-melanom.pdf

Naus, N. C., Verhoeven, A. C., van, D. E., Slater, R., Mooy, C. M., Paridaens, D. A., . . . de, K. A. (2002). Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res, 8(2), 534-539.

NCCN Clinical Practice Guidelines in Oncology: Melanoma. (2013). Fort Washington, PA: National Comprehensive Cancer Network.

New ASCO, SSO guidelines for sentinel lymph node biopsy in melanoma. (2012). Oncology (Williston.Park), 26(9), 841-842.

New German Guidelines for Malignant Melanoma. (2011).

New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. (2006). (NIH Publ No 05-5302). Bethesda, MD: N. I. o. Health. Hentet fra http://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdf

Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y. M., Affleck, P., Elliott, F., . . . Bishop, D. T. (2009). Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol, 27(32), 5439-5444.

Ng, C. H., Wang, J. J., Mitchell, P., Amirul Islam, F. M., & Wong, T. Y. (2009). Prevalence and characteristics of choroidal nevi in an Asian vs white population. Arch Ophthalmol, 127(3), 314-319.

Noel, G., Simon, J. M., Valery, C. A., Cornu, P., Boisserie, G., Ledu, D., . . . Mazeron, J. J. (2002). Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg, 79(3-4), 245-255.

Noorda, E. M., Vrouenraets, B. C., Nieweg, O. E., van Geel, A. N., Eggermont, A. M., & Kroon, B. B. (2006). Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion. Eur J Surg Oncol, 32(3), 318-324.

Norval, M., & Wulf, H. C. (2009). Does chronic sunscreen use reduce vitamin D production to insufficient levels? Br J Dermatol, 161(4), 732-736.

O'Day, S. J., Maio, M., Chiarion-Sileni, V., Gajewski, T. F., Pehamberger, H., Bondarenko, I. N., . . . Wolchok, J. D. (2010). Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol, 21(8), 1712-1717.

Onken, M. D., Worley, L. A., Ehlers, J. P., & Harbour, J. W. (2004). Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res., 64(20), 7205-7209.

Oral malignant melanoma. (7. sept. 2010). [nettside]. Hentet Sept. 2011, fra 
https://oralcancerfoundation.org/facts/rare/oral-malignant-melanoma/

Osterlind, A. (1987). Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer, 40(2), 161-164.

Overett, T. K., & Shiu, M. H. (1985). Surgical treatment of distant metastatic melanoma. Indications and results. Cancer, 56(5), 1222-1230.

Pach, J. M., & Robertson, D. M. (1986). Metastasis from untreated uveal melanomas. Arch Ophthalmol, 104(11), 1624-1625.

Park, S. S., Dong, H., Liu, X., Harrington, S. M., Krco, C. J., Grams, M. P., . . . Kwon, E. D. (2015). PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Cancer immunology research, 3(6), 610-619. https://doi.org/10.1158/2326-6066.Cir-14-0138

Pasquali, S., Mocellin, S., Campana, L. G., Bonandini, E., Montesco, M. C., Tregnaghi, A., . . . Rossi, C. R. (2010). Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis. Cancer, 116(5), 1201-1209.

Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., . . . Young, B. (1990). A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med, 322(8), 494-500.

Patel, S. G., Prasad, M. L., Escrig, M., Singh, B., Shaha, A. R., Kraus, D. H., . . . Shah, J. P. (2002). Primary mucosal malignant melanoma of the head and neck. Head Neck, 24(3), 247-257.

Personlig meddelse (2015).

Pessaux, P., Pocard, M., Elias, D., Duvillard, P., Avril, M. F., Zimmerman, P., & Lasser, P. (2004). Surgical management of primary anorectal melanoma. Br J Surg, 91(9), 1183-1187. https://doi.org/10.1002/bjs.4592

Peters, J. L., Byers, R. M., & Ang, K. K. (1992). Radiotherapy for melanoma. I: C. M. Balch, A. N. Hougton, G. W. Milton, A. J. Sober, & S. Soong (red.), Cutaneous melanoma (2 utg., s. 165-199). Philadelphia: Lippincott.

Peters, S., Voelter, V., Zografos, L., Pampallona, S., Popescu, R., Gillet, M., . . . Leyvraz, S. (2006). Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol, 17(4), 578-583.

Populärvetenskapliga fakta om cancer: cancer i siffror 2009. (2009). Stockholm: Sosialstyrelsen i Sverige.

Prescher, G., Bornfeld, N., Hirche, H., Horsthemke, B., Jockel, K. H., & Becher, R. (1996). Prognostic implications of monosomy 3 in uveal melanoma. Lancet, 347(9010), 1222-1225.

Raivio, I. (1977). Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl, (133), 1-64.

Ribas, A., Puzanov, I., Dummer, R., Schadendorf, D., Hamid, O., Robert, C., . . . Daud, A. (2015). Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncol, 16(8), 908-918. https://doi.org/10.1016/s1470-2045(15)00083-2

Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., . . . Ascierto, P. A. (2015). Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med, 372(4), 320-330. https://doi.org/10.1056/NEJMoa1412082

Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., . . . Ribas, A. (2015). Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med, 372(26), 2521-2532. https://doi.org/10.1056/NEJMoa1503093

Robert, C., Thomas, L., Bondarenko, I., O'Day, S., JW, M. D., Garbe, C., . . . Wolchok, J. D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med, 364(26), 2517-2526.

Robertson, D. M. (2008). Cytogenetics in the management of uveal melanoma: are we there yet? Arch Ophthalmol, 126(3), 409-410.

Robsahm, T. E., Bergva, G., Hestvik, U. E., & Moller, B. (2013). Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008. Melanoma Res., 23(1), 70-78.

Robsahm, T. E., Helsing, P., Nilssen, Y., Vos, L., Rizvi, S. M. H., Akslen, L. A., & Veierød, M. B. (2018). High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clinical Epidemiology, 10, 537-548.

Robsahm, T. E., & Tretli, S. (2001). Cutaneous malignant melanoma in Norway: variation by region of residence before and after the age 17. Cancer Causes Control, 12(6), 569-576.

Robsahm, T. E., Tretli, S., Torjesen, P. A., Babigumira, R., & Schwartz, G. G. (2019). Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis. Clinical Epidemiology, 11, 695-705. https://doi.org/10.2147/CLEP.S207230

Rodriguez Rivera, A. M., Alabbas, H., Ramjaun, A., & Meguerditchian, A. N. (2014). Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis. Surg Oncol, 23(1), 11-16. https://doi.org/10.1016/j.suronc.2014.01.002

Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010). Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol, 28(18), 3042-3047. https://doi.org/10.1200/jco.2009.26.2063

Ross, M., Pezzi, C., Pezzi, T., Meurer, D., Hickey, R., & Balch, C. (1990). Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg, 125(3), 313-316. https://doi.org/10.1001/archsurg.1990.01410150035007

Rossi, C. R., Mocellin, S., Scagnet, B., Foletto, M., Vecchiato, A., Pilati, P., . . . Lise, M. (2003). The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol, 83(2), 80-84.

Roumen, R. M. (1996). Anorectal melanoma in The Netherlands: a report of 63 patients. Eur J Surg Oncol, 22(6), 598-601. https://doi.org/10.1016/s0748-7983(96)92346-x

Rueth, N. M., Cromwell, K. D., & Cormier, J. N. (2015). Long-term follow-up for melanoma patients: is there any evidence of a benefit? Surgical oncology clinics of North America, 24(2), 359-377. https://doi.org/10.1016/j.soc.2014.12.012

Rueth, N. M., Xing, Y., Chiang, Y. J., Cromwell, K. D., Ross, M. I., Lee, J. E., . . . Cormier, J. N. (2014). Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg, 259(6), 1215-1222. https://doi.org/10.1097/sla.0000000000000233

Rutkowski, P., & Lugowska, I. (2014). Follow-up in melanoma patients. Memo, 7(2), 83-86. https://doi.org/10.1007/s12254-014-0151-y

Sainsbury, R., Haward, B., Rider, L., Johnston, C., & Round, C. (1995). Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet, 345(8960), 1265-1270. https://doi.org/10.1016/s0140-6736(95)90924-9

Salmon, R. J., Levy, C., Plancher, C., Dorval, T., Desjardins, L., Leyvraz, S., . . . Asselain, B. (1998). Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol, 24(2), 127-130.

Sammen - mot kreft: nasjonal kreftstrategi 2013–2017. (2013). Oslo: Helse- og omsrogsdepartementet. Hentet fra 
https://www.iccp-portal.org/system/files/plans/kreftstrategien_2013.pdf

Saw, R., Menzies, A., McArthur, G., Spillane, J., Haydon, A., & Cancer Council Australia Melanoma Guidelines Working Party. (25. mai 2018). What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed? I: Clinical practice guidelines for the diagnosis and management of melanoma. [nettdokument]. Sydney: Cancer Council Australia. Hentet 17. mars 2019, fra https://wiki.cancer.org.au/australiawiki/index.php?oldid=186475

Schroer-Gunther, M. A., Wolff, R. F., Westwood, M. E., Scheibler, F. J., Schurmann, C., Baumert, B. G., . . . Kleijnen, J. (2012). F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review. Syst Rev, 1, 62. https://doi.org/10.1186/2046-4053-1-62

Schule, S. C., Eigentler, T. K., Garbe, C., la Fougere, C., Nikolaou, K., & Pfannenberg, C. (2016). Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma. Eur J Nucl Med Mol Imaging, 43(3), 482-488. https://doi.org/10.1007/s00259-015-3187-2

Scientific Committee on Health, Environmental and Emerging Risks - SCHEER. (2016). Opinion on biological effects of ultraviolet radiation relevant to health with particular reference to sunbeds for cosmetic purposes. Luxembourg: European Commission. Hentet fra https://ec.europa.eu/health/sites/health/files/scientific_committees/scheer/docs/scheer_o_003.pdf

Scolyer, R. A., Murali, R., McCarthy, S. W., & Thompson, J. F. (2008). Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol, 25(2), 100-111.

Selvåg, E. (2003). Legemidler og sol. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 123(13-14), 1860-1861.

Seneffekter etter kreftbehandling: faglige råd. (2017). (IS-2551). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/publikasjoner/seneffekter-etter-kreft

Seregard, S. (1998). Conjunctival melanoma. Surv Ophthalmol, 42(4), 321-350.

Seregard, S. (1999). Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand, 77(4), 414-417.

Seregard, S., & Kock, E. (1995). Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand, 73(4), 340-344.

Shah, C. P., Weis, E., Lajous, M., Shields, J. A., & Shields, C. L. (2005). Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology, 112(9), 1599-1607.

Shields, C. L., Cater, J., Shields, J. A., Singh, A. D., Santos, M. C., & Carvalho, C. (2000). Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol, 118(3), 360-364.

Shields, C. L., Furuta, M., Berman, E. L., Zahler, J. D., Hoberman, D. M., Dinh, D. H., . . . Shields, J. A. (2009). Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol, 127(8), 981-987.

Shields, C. L., Ganguly, A., Materin, M. A., Teixeira, L., Mashayekhi, A., Swanson, L. A., . . . Shields, J. A. (2007). Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol, 125(8), 1017-1024.

Shields, C. L., Materin, M. A., Teixeira, L., Mashayekhi, A., Ganguly, A., & Shields, J. A. (2007). Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy. Ophthalmology, 114(10), 1919-1924.

Shields, C. L., Shields, J. A., Cater, J., Gunduz, K., Miyamoto, C., Micaily, B., & Brady, L. W. (2000). Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol, 118(9), 1219-1228.

Shields, C. L., Shields, J. A., Karlsson, U., Menduke, H., & Brady, L. W. (1990). Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings. Ophthalmology, 97(12), 1665-1670.

Shields, C. L., Shields, J. A., Perez, N., Singh, A. D., & Cater, J. (2002). Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology, 109(2), 225-234.

Singh, A. D., & Borden, E. C. (2005). Metastatic uveal melanoma. Ophthalmol Clin North Am, 18(1), 143-150, ix.

Singh, A. D., Shields, C. L., & Shields, J. A. (2001). Prognostic factors in uveal melanoma. Melanoma Res., 11(3), 255-263.

Singh, A. D., Shields, C. L., Shields, J. A., & Sato, T. (2000). Uveal melanoma in young patients. Arch Ophthalmol, 118(7), 918-923.

Singh, A. D., & Topham, A. (2003). Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology, 110(5), 962-965.

Sisley, K., Nichols, C., Parsons, M. A., Farr, R., Rees, R. C., & Rennie, I. G. (1998). Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye (Lond), 12 ( Pt 2), 203-207.

Sladden, M., Nieweg, O. E., Hovwle, J., Coverntry, B., & Cancer Council Australia Melanoma Guidelines Working Party. (17. mai 2018). What are the recommended safety margins for radical excision of primary melanoma? I: Clinical practice guidelines for the diagnosis and management of melanoma. [nettdokument]. Sydney: Cancer Council Australia. Hentet 18. mai 2018, fra https://wiki.cancer.org.au/australia/Clinical_question:What_are_the_recommended_safety_margins_for_radical_excision_of_primary_melanoma%3F/Invasive_melanoma

Sladden, M. J., Balch, C., Barzilai, D. A., Berg, D., Freiman, A., Handiside, T., . . . Thompson, J. F. (2009). Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev, (4), CD004835.

Slingluff, C. L., Jr., Vollmer, R. T., & Seigler, H. F. (1990). Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery, 107(1), 1-9.

Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J., Roberge, D., . . . Mehta, M. (2010). Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. International journal of radiation oncology, biology, physics, 77(3), 655-661. https://doi.org/10.1016/j.ijrobp.2009.08.025

Stang, A., Anastassiou, G., Ahrens, W., Bromen, K., Bornfeld, N., & Jockel, K. H. (2001). The possible role of radiofrequency radiation in the development of uveal melanoma. Epidemiology, 12(1), 7-12.

Stang, A., Jöckel, K. H., & Heidinger, O. (2018). Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015). European journal of epidemiology, 33(3), 303-312. https://doi.org/10.1007/s10654-017-0348-6

Stang, A., Streller, B., Eisinger, B., & Jöckel, K. H. (2005). Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecologic oncology, 96(1), 216-221. https://doi.org/10.1016/j.ygyno.2004.09.052

Sterne, G. D., Murray, D. S., & Grimley, R. P. (1995). Ilioinguinal block dissection for malignant melanoma. Br J Surg, 82(8), 1057-1059.

Stone, C. A., & Goodacre, T. E. (1995). Surgical management of regional lymph nodes in primary cutaneous malignant melanoma. Br J Surg, 82(8), 1015-1022.

Sullivan, R. J., & Flaherty, K. T. (2013). Resistance to BRAF-targeted therapy in melanoma. Eur J Cancer, 49(6), 1297-1304. https://doi.org/10.1016/j.ejca.2012.11.019

Sumich, P., Mitchell, P., & Wang, J. J. (1998). Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol, 116(5), 645-650.

Suwandinata, F. S., Bohle, R. M., Omwandho, C. A., Tinneberg, H. R., & Gruessner, S. E. (2007). Management of vulvar melanoma and review of the literature. European journal of gynaecological oncology, 28(3), 220-224.

Svedman, F. C., Pillas, D., Taylor, A., Kaur, M., Linder, R., & Hansson, J. (2016). Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clinical Epidemiology, 8, 109-122. https://doi.org/10.2147/clep.S99021

Tchelebi, L., Guirguis, A., & Ashamalla, H. (2016). Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy. Journal of cancer research and clinical oncology, 142(12), 2569-2575. https://doi.org/10.1007/s00432-016-2245-x

Thibault, C., Sagar, P., Nivatvongs, S., Ilstrup, D. M., & Wolff, B. G. (1997). Anorectal melanoma--an incurable disease? Diseases of the colon and rectum, 40(6), 661-668. https://doi.org/10.1007/bf02140894

Thomas, J. M. (2008). Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol, 5(1), 18-23.

Thompson, J. F., & Kam, P. C. (2008). Current status of isolated limb infusion with mild hyperthermia for melanoma. Int J Hyperthermia, 24(3), 219-225.

TNM classification of malignant tumours. (2017). (8. utg.). Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell.

Trimble, E. L., Lewis, J. L., Jr., Williams, L. L., Curtin, J. P., Chapman, D., Woodruff, J. M., . . . Hoskins, W. J. (1992). Management of vulvar melanoma. Gynecologic oncology, 45(3), 254-258. https://doi.org/10.1016/0090-8258(92)90300-8

Trotter, S. C., Sroa, N., Winkelmann, R. R., Olencki, T., & Bechtel, M. (2013). A Global Review of Melanoma Follow-up Guidelines. The Journal of clinical and aesthetic dermatology, 6(9), 18-26.

Tzellos, T., Kyrgidis, A., Mocellin, S., Chan, A. W., Pilati, P., & Apalla, Z. (2014). Interventions for melanoma in situ, including lentigo maligna. Cochrane Database Syst Rev, (12), Cd010308. https://doi.org/10.1002/14651858.CD010308.pub2

Ulrich, J., van Akkooi, A. J., Eggermont, A. M., & Voit, C. (2011). New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB). Expert Rev Anticancer Ther, 11(11), 1693-1701.

van Akkooi, A. C., de Wilt, J. H., Verhoef, C., Schmitz, P. I., van Geel, A. N., Eggermont, A. M., & Kliffen, M. (2006). Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol, 17(10), 1578-1585.

van Geel, A. N., den Bakker, M. A., Kirkels, W., Horenblas, S., Kroon, B. B., de Wilt, J. H., . . . van der Aa, M. N. (2007). Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology, 70(1), 143-147.

Veileder i biopsibesvarelse av maligne svulster. (2001). Oslo: Den norske lægeforening.

Vensby, P. H., Schmidt, G., Kjær, A., & Fischer, B. M. (2017). The value of FDG PET/CT for follow-up of patients with melanoma: a retrospective analysis. American journal of nuclear medicine and molecular imaging, 7(6), 255-262.

Verschraegen, C. F., Benjapibal, M., Supakarapongkul, W., Levy, L. B., Ross, M., Atkinson, E. N., . . . Legha, S. S. (2001). Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 11(5), 359-364. 

Vestergaard, M. E., Macaskill, P., Holt, P. E., & Menzies, S. W. (2008). Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol, 159(3), 669-676.

Voit, C., Kron, M., Schafer, G., Schoengen, A., Audring, H., Lukowsky, A., . . . Rademaker, J. (2006). Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol, 13(12), 1682-1689.

Voit, C., van Akkooi, A. C., Schafer-Hesterberg, G., Schoengen, A., Kowalczyk, K., Roewert, J. C., . . . Eggermont, A. M. (2010). Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol, 28(5), 847-852.

Voit, C. A., van Akkooi, A. C., Schäfer-Hesterberg, G., Schoengen, A., Schmitz, P. I., Sterry, W., & Eggermont, A. M. (2009). Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol, 27(30), 4994-5000. https://doi.org/10.1200/jco.2008.19.0033

Wagoner, M. D., & Albert, D. M. (1982). The incidence of metastases from untreated ciliary body and choroidal melanoma. Arch Ophthalmol, 100(6), 939-940.

Waldeland, E., Brustugun, O. T., Ramberg, C., & Helland, Å. (2012). Stereotaktisk bestråling av columnametastaser. Tidsskr Nor Legeforen, 132(22), 2478-2479.

Warycha, M. A., Zakrzewski, J., Ni, Q., Shapiro, R. L., Berman, R. S., Pavlick, A. C., . . . Osman, I. (2009). Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm). Cancer, 115(4), 869-879.

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., . . . Ascierto, P. A. (2017). Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med, 377(19), 1824-1835. https://doi.org/10.1056/NEJMoa1709030

Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., . . . Larkin, J. (2015). Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol, 16(4), 375-384. https://doi.org/10.1016/s1470-2045(15)70076-8

Weyandt, G. H., Eggert, A. O., Houf, M., Raulf, F., Bröcker, E. B., & Becker, J. C. (2003). Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer, 89(11), 2019-2022. https://doi.org/10.1038/sj.bjc.6601409

Wheatley, K., Wilson, J., Gaunt, P., & Marsden, J. (2013). Are narrow surgical excision margins for primary cutaneous melanoma safe? An updated systematic review and meta-analysis. JDDG - Journal of the German Society of Dermatology, 7), 10. https://doi.org/10.1111/ddg.12160

Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., . . . Larkin, J. (2017). Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. N Engl J Med, 377(14), 1345-1356. https://doi.org/10.1056/NEJMoa1709684

Wolchok, J. D., Neyns, B., Linette, G., Negrier, S., Lutzky, J., Thomas, L., . . . Lebbe, C. (2010). Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol., 11(2), 155-164.

Wong, S. L., Balch, C. M., Hurley, P., Agarwala, S. S., Akhurst, T. J., Cochran, A., . . . Lyman, G. H. (2012). Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol, 30(23), 2912-2918.

Wu, S., Han, J., Feskanich, D., Cho, E., Stampfer, M. J., Willett, W. C., & Qureshi, A. A. (2015). Citrus Consumption and Risk of Cutaneous Malignant Melanoma. J Clin Oncol, 33(23), 2500-2508. https://doi.org/10.1200/jco.2014.57.4111

Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., . . . Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst, 103(2), 129-142.

Yao, K., Balch, G., & Winchester, D. J. (2009). Multidisciplinary treatment of primary melanoma. Surg Clin North Am, 89(1), 267-281, xi.

Yeh, J. J., Shia, J., Hwu, W. J., Busam, K. J., Paty, P. B., Guillem, J. G., . . . Weiser, M. R. (2006). The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg, 244(6), 1012-1017. https://doi.org/10.1097/01.sla.0000225114.56565.f9

Young, T. A., Burgess, B. L., Rao, N. P., Gorin, M. B., & Straatsma, B. R. (2007). High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Mol Vis, 13, 2328-2333.

Aaberg, T. M., Jr., Bergstrom, C. S., Hickner, Z. J., & Lynn, M. J. (2008). Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol, 92(6), 741-746.